ulbi20231025

0001437749-23-029034.txt : 20231026 0001437749-23-029034.hdr.sgml : 20231026 20231026073010 ACCESSION NUMBER: 0001437749-23-029034 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20231026 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231026 DATE AS OF CHANGE: 20231026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ULTRALIFE CORP CENTRAL INDEX KEY: 0000875657 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 161387013 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20852 FILM NUMBER: 231347499 BUSINESS ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 BUSINESS PHONE: 3153327100 MAIL ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 FORMER COMPANY: FORMER CONFORMED NAME: ULTRALIFE BATTERIES INC DATE OF NAME CHANGE: 19940224 8-K 1 ulbi20231025_8k.htm FORM 8-K ulbi20231025_8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

October 26, 2023

Date of Report (Date of Earliest Event Reported)


ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)

Delaware

000-20852

16-1387013

(State of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

2000 Technology Parkway, Newark, New York 14513

(Address of principal executive offices) (Zip Code)

(315) 332-7100

(Registrant’s telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Act:

Common Stock, $0.10 par value per share

ULBI

NASDAQ

(Title of each class)

(Trading Symbol)

(Name of each exchange on which registered)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

On October 26, 2023, Ultralife Corporation issued a press release regarding the financial results for its third quarter ended September 30, 2023. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.

Item 9.01 Financial Statements, Pro Forma Financials and Exhibits

(d) Exhibits.

Exhibit Number		Exhibit Description
99.1		Press Release of Ultralife Corporation dated October 26, 2023
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 26, 2023		ULTRALIFE CORPORATION


	By:	/s/ Philip A. Fain
		Philip A. Fain
		Chief Financial Officer and Treasurer

EX-99.1 2 ex_585556.htm EXHIBIT 99.1 ex_585556.htm

Exhibit 99.1

Ultralife Corporation Reports Third Quarter Results

NEWARK, N.Y. – October 26, 2023 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2023 with the following highlights:

●

Sales of $39.5 million representing an 18.8% year-over-year increase

●

Operating income of $2.1 million versus a loss of $0.6 million for the 2022 third quarter

●

Adjusted EPS of $0.10 compared to a loss of $0.03 for the 2022 third quarter

●

Adjusted EBITDA of $3.5 million representing a 177.3% year-over-year increase

●

Backlog of $101.1 million exiting the 2023 third quarter

“Driven by continuing strong demand from our government/defense and medical customers, sales grew 19% for both the 2023 third quarter and the first nine months to $39.5 million and $114.1 million, respectively, over the prior year periods. We continue to focus on recapturing gross margin through price realization, lean manufacturing initiatives and level-loaded production, which resulted in a year-over-year improvement in gross margin of 460 basis points to 24.8% for the third quarter. On the strength of higher sales, gross margin improvement and disciplined spending, operating profit of $2.1 million far exceeded the operating loss of $0.6 million from the year-earlier quarter. Finally, our efforts to strengthen our relationships with key customers using our global new product development resources are bearing fruit as we continue to sustain our backlog in excess of $100 million,” said Mike Manna, President and Chief Executive Officer. “As we close out 2023 with a strong backlog, we are well positioned to continue our profitable growth and to generate incremental cashflow to reduce our acquisition debt and further invest in our businesses, including new product development, strategic capital expenditures and accretive acquisitions.”

Third Quarter 2023 Financial Results

Revenue was $39.5 million, an increase of $6.3 million, or 18.8%, as compared to revenue of $33.2 million for the third quarter of 2022. Overall, government/defense sales increased 48.1% and commercial sales increased 5.6% over the 2022 period. Battery & Energy Products sales increased 11.7% to $31.9 million compared to $28.6 million last year, reflecting increases of 36.2% in government/defense sales and 37.9% in medical battery sales, partially offset by decreases of 1.8% in oil & gas market sales and 14.9% in other commercial sales. Communications Systems sales increased by 62.7% to $7.6 million compared to $4.7 million for the same period last year, primarily attributable to shipments of vehicle-amplifier adaptors to a global defense contractor for the U.S. Army and of integrated systems of amplifiers and radio vehicle mounts to a major international defense contractor under an ongoing allied country government/defense modernization program. Our total backlog exiting the 2023 third quarter was $101.1 million with over $35 million of the total backlog due to ship over the remaining three months of 2023.

Gross profit was $9.8 million, or 24.8% of revenue, compared to $6.7 million, or 20.2% of revenue, for the same quarter a year ago. Battery & Energy Products gross margin was 24.2%, compared to 18.7% last year, primarily due to more efficiencies and higher cost absorption resulting from a concerted effort to level-load production more evenly across the 2023 quarter, as well as improved price realization. Communications Systems gross margin was 27.0% compared to 29.5% last year, primarily due to inefficiencies caused by component delays from suppliers, partially offset by higher factory volume.

Operating expenses were $7.6 million, compared to $7.3 million for the 2022 third quarter. Operating expenses were 19.3% of revenue compared to 22.0% of revenue for the year-earlier period.

The combination of higher gross profit and leveraging of operating expenses resulted in a $2.7 million increase in operating income to $2.1 million from an operating loss of $0.6 million last year.

Net income was $1.3 million or $0.08 per diluted share on a GAAP basis, compared to a net loss of $0.2 million or $0.01 per diluted share for the third quarter of 2022. Adjusted EPS was $0.10 on a diluted basis for the third quarter of 2023, compared to a loss of $0.03 for the 2022 period. Adjusted EPS excludes the provision for deferred taxes of $0.4 million which primarily represents non-cash charges for U.S. taxes which we expect will be fully offset by net operating loss carryforwards and other tax credits for the foreseeable future.

Adjusted EBITDA, defined as EBITDA including non-cash, stock-based compensation expense, was $3.5 million for the third quarter of 2023, or 8.8% of sales, compared to $1.3 million, or 3.8% of sales, for the year-earlier period.

See the “Non-GAAP Financial Measures” section of this release for a reconciliation of adjusted EPS to EPS and adjusted EBITDA to net income attributable to Ultralife Corporation.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government/defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

Conference Call Information

Ultralife will hold its third quarter earnings conference call today at 8:30 AM ET.

To ensure a fast and reliable connection to our investor conference call, we now require participants dialing in by phone to register using the following link prior to the call: https://register.vevent.com/register/BI7f14d2264d2242c1adb217d21d75ab21. This will eliminate the need to speak with an operator. Once registered, dial-in information will be provided along with a personal identification number. Should you register early and misplace your details, you can simply click back on this same link at any time to register and view this information again. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company's website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include the impact of COVID-19 and related supply chain disruptions, potential reductions in revenues from key customers, acceptance of our new products on a global basis and uncertain global economic conditions. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

(Unaudited)

ASSETS

	September 30, 2023			December 31, 2022
Current Assets:
Cash	$	9,301		$	5,713
Trade Accounts Receivable, Net		27,189			27,779
Inventories, Net		46,634			41,192
Prepaid Expenses and Other Current Assets		6,429			4,304
Total Current Assets		89,553			78,988

Property, Plant and Equipment, Net		21,166			21,716
Goodwill		37,357			37,428
Other Intangible Assets, Net		15,270			15,921
Deferred Income Taxes, Net		10,728			12,069
Other Non-Current Assets		2,035			2,308
Total Assets	$	176,109		$	168,430

LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts Payable	$	13,470		$	16,074
Current Portion of Long-Term Debt		2,000			2,000
Accrued Compensation and Related Benefits		2,467			2,890
Accrued Expenses and Other Current Liabilities		8,449			7,949
Total Current Liabilities		26,386			28,913
Long-Term Debt, Net		24,108			19,310
Deferred Income Taxes		1,825			1,917
Other Non-Current Liabilities		2,032			1,887
Total Liabilities		54,351			52,027

Shareholders' Equity:
Common Stock		2,075			2,057
Capital in Excess of Par Value		188,852			187,405
Accumulated Deficit		(43,627	)		(47,951	)
Accumulated Other Comprehensive Loss		(4,176	)		(3,750	)
Treasury Stock		(21,484	)		(21,484	)
Total Ultralife Equity		121,640			116,277
Non-Controlling Interest		118			126
Total Shareholders’ Equity		121,758			116,403

Total Liabilities and Shareholders' Equity	$	176,109		$	168,430

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands Except Per Share Amounts)
(Unaudited)

	Three-Month Period Ended						Nine-Month Period Ended
	September 30,			September 30,			September 30,			September 30,
	2023			2022			2023			2022
Revenues:
Battery & Energy Products	$	31,919		$	28,583		$	94,250		$	87,873
Communications Systems		7,569			4,651			19,846			7,860
Total Revenues		39,488			33,234			114,096			95,733

Cost of Products Sold:
Battery & Energy Products		24,191			23,238			72,467			68,656
Communications Systems		5,523			3,281			13,831			5,758
Total Cost of Products Sold		29,714			26,519			86,298			74,414

Gross Profit		9,774			6,715			27,798			21,319

Operating Expenses:
Research and Development		1,869			1,896			5,679			5,425
Selling, General and Administrative		5,770			5,405			16,293			15,982
Total Operating Expenses		7,639			7,301			21,972			21,407

Operating Income (Loss)		2,135			(586	)		5,826			(88	)

Other Income (Expense)		(386	)		254			178			22
Income (Loss) Before Income Taxes		1,749			(332	)		6,004			(66	)

Income Tax Provision (Benefit)		446			(90	)		1,688			(171	)

Net Income (Loss)		1,303			(242	)		4,316			105

Net (Loss) Income Attributable to Non-Controlling Interest		(27	)		(3	)		(8	)		-

Net Income (Loss) Attributable to Ultralife Corporation	$	1,330		$	(239	)	$	4,324		$	105


Net Income (Loss) Per Share Attributable to Ultralife Common Shareholders – Basic	$	.08		$	(.01	)	$	.27		$	.01

Net Income (Loss) Per Share Attributable to Ultralife Common Shareholders – Diluted	$	.08		$	(.01	)	$	.27		$	.01

Weighted Average Shares Outstanding – Basic		16,238			16,133			16,172			16,122

Weighted Average Shares Outstanding – Diluted		16,303			16,133			16,174			16,144

Non-GAAP Financial Measures

Adjusted EBITDA

In evaluating our business, we consider and use adjusted EBITDA, a non-GAAP financial measure, as a supplemental measure of our operating performance in addition to U.S. Generally Accepted Accounting Principles (“GAAP”) financial measures. We define adjusted EBITDA as net income attributable to Ultralife Corporation before net interest expense, provision (benefit) for income taxes, depreciation and amortization, and stock-based compensation expense, plus/minus expense/income that we do not consider reflective of our ongoing continuing operations. We reconcile adjusted EBITDA to net income attributable to Ultralife Corporation, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EBITDA as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EBITDA to net income attributable to Ultralife Corporation.

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EBITDA

(Dollars in Thousands)

(Unaudited)

	Three-Month Period Ended					Nine-Month Period Ended
	September 30, 2023		September 30, 2022			September 30, 2023		September 30, 2022

Net Income (Loss) Attributable to Ultralife Corporation	$	1,330	$	(239	)	$	4,324	$	105
Adjustments:
Interest Expense, Net		586		272			1,450		583
Income Tax Provision (Benefit)		446		(90	)		1,688		(171	)
Depreciation Expense		760		815			2,282		2,450
Amortization Expense		227		318			663		969
Stock-Based Compensation Expense		131		179			424		552
Cyber-Insurance Policy Deductible		-		-			100		-
Non-Cash Purchase Accounting Adjustment		-		-			-		55
Adjusted EBITDA	$	3,480	$	1,255		$	10,931	$	4,543

Adjusted Earnings Per Share

In evaluating our business, we consider and use adjusted EPS, a non-GAAP financial measure, as a supplemental measure of our business performance. We define adjusted EPS as net income attributable to Ultralife Corporation excluding the provision (benefit) for deferred income taxes divided by our weighted average shares outstanding on both a basic and diluted basis. We believe that this information is useful in providing period-to-period comparisons of our results by reflecting the portion of our tax provision that we expect will be predominantly offset by our U.S. net operating loss carryforwards and other tax credits for the foreseeable future. We reconcile adjusted EPS to EPS, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EPS as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EPS to EPS and net income attributable to Ultralife Corporation.

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EPS

(In Thousands Except Per Share Amounts)

(Unaudited)

	Three-Month Period Ended
	September 30, 2023						September 30, 2022
	Amount		Per Basic Share		Per Diluted Share		Amount			Per Basic Share			Per Diluted Share
Net Income (Loss) Attributable to Ultralife Corporation	$	1,330	$	.08	$	.08	$	(239	)	$	(.01	)	$	(.01	)
Deferred Tax Provision (Benefit)		357		.02		.02		(308	)		(.02	)		(.02	)
Adjusted Net Income (Loss)	$	1,687	$	.10	$	.10	$	(547	)	$	(.03	)	$	(.03	)

Weighted Average Shares Outstanding				16,238		16,303					16,133			16,133

	Nine-Month Period Ended
	September 30, 2023						September 30, 2022
	Amount		Per Basic Share		Per Diluted Share		Amount			Per Basic Share			Per Diluted Share
Net Income Attributable to Ultralife Corporation	$	4,324	$	.27	$	.27	$	105		$	.01		$	.01
Deferred Tax Provision (Benefit)		1,245		.07		.07		(683	)		(.05	)		(.05	)
Adjusted Net Income (Loss)	$	5,569	$	.34	$	.34	$	(578	)	$	(.04	)	$	(.04	)

Weighted Average Shares Outstanding				16,172		16,174					16,122			16,144

Company Contact:

Ultralife Corporation

Philip A. Fain

(315) 210-6110

pfain@ulbi.com

Investor Relations Contact:

LHA

Jody Burfening

(212) 838-3777

jburfening@lhai.com

EX-101.SCH 3 ulbi-20231026.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 ulbi-20231026_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 ulbi-20231026_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 ulbi-20231026_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 logo.jpg begin 644 logo.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information	Oct. 26, 2023
Document Information [Line Items]
Entity, Registrant Name	ULTRALIFE CORPORATION
Document, Type	8-K
Document, Period End Date	Oct. 26, 2023
Entity, Incorporation, State or Country Code	DE
Entity, File Number	000-20852
Entity, Tax Identification Number	16-1387013
Entity, Address, Address Line One	2000 Technology Parkway
Entity, Address, City or Town	Newark
Entity, Address, State or Province	NY
Entity, Address, Postal Zip Code	14513
City Area Code	315
Local Phone Number	332-7100
Title of 12(b) Security	Common Stock
Trading Symbol	ULBI
Security Exchange Name	NASDAQ
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity, Emerging Growth Company	false
Amendment Flag	false
Entity, Central Index Key	0000875657

XML 9 ulbi20231025_8k_htm.xml IDEA: XBRL DOCUMENT 0000875657 2023-10-26 2023-10-26 false 0000875657 8-K 2023-10-26 ULTRALIFE CORPORATION DE 000-20852 16-1387013 2000 Technology Parkway Newark NY 14513 315 332-7100 Common Stock ULBI NASDAQ false false false false false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.ulbi.com/20231026/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports ulbi-20231026.xsd ulbi-20231026_def.xml ulbi-20231026_lab.xml ulbi-20231026_pre.xml ulbi20231025_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ulbi20231025_8k.htm": { "nsprefix": "ulbi", "nsuri": "http://www.ulbi.com/20231026", "dts": { "schema": { "local": [ "ulbi-20231026.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "ulbi-20231026_def.xml" ] }, "labelLink": { "local": [ "ulbi-20231026_lab.xml" ] }, "presentationLink": { "local": [ "ulbi-20231026_pre.xml" ] }, "inline": { "local": [ "ulbi20231025_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.ulbi.com/20231026/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20238K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ulbi20231025_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20238K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ulbi20231025_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.ulbi.com/20231026/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001437749-23-029034-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-029034-xbrl.zip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end